Walker Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$433K Buy
2,983
+19
+0.6% +$2.62K 0.22% 91
2026
Q2
$381K Buy
2,964
+20
+0.7% +$2.34K 0.19% 103
2026
Q1
$354K Buy
2,944
+85
+3% +$9.8K 0.19% 102
2025
Q4
$301K Buy
2,859
+24
+0.8% +$2.25K 0.16% 110
2025
Q3
$238K Sell
2,835
-74
-3% -$6.1K 0.13% 117
2025
Q2
$230K Buy
2,909
+120
+4% +$9.5K 0.13% 122
2025
Q1
$250K Buy
2,789
+54
+2% +$5.04K 0.15% 118
2024
Q4
$272K Buy
2,735
+118
+5% +$12.2K 0.17% 107
2024
Q3
$297K Sell
2,617
-55
-2% -$6.53K 0.18% 98
2024
Q2
$331K Sell
2,672
-25
-0.9% -$3.22K 0.22% 86
2024
Q1
$356K Buy
2,697
+16
+0.6% +$1.97K 0.24% 80
2023
Q4
$292K Buy
+2,681
New +$278K 0.21% 93

Other funds holding MRK

Walker Asset Management's MRK Position: Q3 2026 in Review

Walker Asset Management increased its Merck (MRK) stake by 0.64% in Q3 2026, buying an estimated $2.62K and bringing the position to 2,983 shares worth $433K. The position accounts for 0.22% of the portfolio, ranked #91.

Walker Asset Management first reported a position in MRK in Q4 2023 and has held it in 12 quarters since. 1,610 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Walker Asset Management held 2,983 shares of Merck worth $433K as of Q3 2026.
  • Walker Asset Management bought 19 Merck shares in Q3 2026, an estimated $2.62K.
  • Merck made up 0.22% of Walker Asset Management's portfolio in Q3 2026, its #91 holding.
  • Walker Asset Management first reported a position in Merck in Q4 2023 and has held it in 12 quarters since.
  • 1,610 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Walker Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.